Related Experiment Videos
Oxidative stress and apoptosis in heart dysfunction.
Dinender Kumar1, Huiquan Lou, Pawan K Singal
1Cardiovascular Research Group, Department of Medicine, University of Wisconsin, Madison, WI, USA.
Herz
|November 20, 2002
Summary
Antioxidants show promise in treating heart disease by inhibiting apoptosis, a process causing myocyte cell loss. This discovery offers new therapeutic avenues for cardiovascular conditions.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Heart disease pathogenesis involves complex mechanisms, including myocyte cell loss via apoptosis.
- Apoptosis is implicated in myocardial infarction, ischemia-reperfusion injury, heart failure, and cardiomyopathy.
Purpose of the Study:
- To elucidate the role of apoptosis in cardiac dysfunction.
- To investigate the regulatory processes of apoptosis in the heart.
- To explore potential therapeutic targets for heart disease.
Main Methods:
- Review of documented apoptotic regulatory pathways in cardiac disease.
- Analysis of pro-apoptotic (Bax, caspases, cytochrome c) and anti-apoptotic (Bcl-2, Akt, IAPs) protein expression.
- Investigation of the role of mitogen-activated protein kinases (MAPKs) in apoptosis and survival.
- Evaluation of oxidative stress and antioxidant effects on apoptotic pathways.
Main Results:
- Upregulation of pro-apoptotic proteins and/or downregulation of anti-apoptotic proteins are observed in cardiac diseases.
- Mitogen-activated protein kinases (MAPKs) play a dual role in apoptosis and cell survival.
- Inhibition of apoptotic pathways (e.g., caspase inhibitors, Bcl-2, Akt overexpression) can block apoptosis.
- Oxidative stress promotes apoptosis, while antioxidants inhibit this process.
Conclusions:
- Antioxidants demonstrate potential in inhibiting apoptotic pathways.
- This finding suggests novel therapeutic strategies for treating various heart diseases.